Research

Hormonal

Combined treatment with exenatide and metformin is superior to either drug alone for improving menstrual cyclicity, ovulation rates, and reducing central adiposity in overweight women with PCOS.

For overweight women with PCOS struggling with irregular periods, combining Metformin and Exenatide appears more effective than using either drug alone. This combination significantly improves ovulation rates and reduces abdominal fat. While Exenatide requires injections, side effects like nausea are common but manageable with dose titration. This approach targets both insulin resistance and hormonal imbalances simultaneously.

ModerateSupportsMEDIUM confidence
COM therapy was superior to EX or MET monotherapy in improving menstrual cyclicity, ovulation rate, free androgen index, and insulin sensitivity measures and reducing weight and abdominal fat.
Karen Elkind‐Hirsch et al. · The Journal of Clinical Endocrinology & Metabolism · 2008

Why this rating

Small sample size (n=60, 42 completed), open-label design, and high dropout rate (30%) limit generalizability, though results are statistically significant.

Source

Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome

Karen Elkind‐Hirsch et al. · The Journal of Clinical Endocrinology & Metabolism · 2008

DOI 10.1210/jc.2008-0115

rct · n=60Cited 267×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →